Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.3300
0.039.16%
At close: -
$0.3200
-0.01-3.03%
After Hours: 7:14 PM EDT
Comments
Loading...
Athira Pharma Analyst Ratings and Price Targets | NASDAQ:ATHA | Benzinga
Athira Pharma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Athira Pharma Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Mizuho
Rodman & Renshaw
Stifel
Jefferies
1calculated from analyst ratings
Analyst Ratings for Athira Pharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 09/19/2024 | Buy Now | — | Mizuho | Graig Suvannavejh51% | $5 → $0.5 | Downgrade | Outperform → Neutral | Get Alert |
| 09/04/2024 | Buy Now | — | JMP Securities | Jason Butler50% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 09/04/2024 | Buy Now | — | BTIG | Thomas Shrader39% | — | Downgrade | Buy → Neutral | Get Alert |
| 08/19/2024 | Buy Now | — | Rodman & Renshaw | Elemer Piros53% | → $22 | Initiates | → Buy | Get Alert |
| 06/20/2024 | Buy Now | — | JMP Securities | Jason Butler50% | $19 → $19 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/16/2024 | Buy Now | — | JMP Securities | Jason Butler50% | $19 → $19 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/11/2023 | Buy Now | — | JMP Securities | Jason Butler50% | $20 → $19 | Maintains | Outperform | Get Alert |
| 05/15/2023 | Buy Now | — | Mizuho | Graig Suvannavejh51% | $6 → $5 | Maintains | Buy | Get Alert |
| 03/30/2023 | Buy Now | — | BTIG | Thomas Shrader39% | $33 → $10 | Maintains | Buy | Get Alert |
| 03/24/2023 | Buy Now | — | JMP Securities | Jason Butler50% | → $20 | Reiterates | → Market Outperform | Get Alert |
| 07/07/2022 | Buy Now | — | Mizuho | Graig Suvannavejh51% | → $6 | Initiates | → Buy | Get Alert |
| 06/23/2022 | Buy Now | — | Stifel | Paul Matteis44% | $36 → $5 | Downgrade | Buy → Hold | Get Alert |
| 06/23/2022 | Buy Now | — | JMP Securities | Jason Butler50% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 06/23/2022 | Buy Now | — | Jefferies | Andrew Tsai25% | $32 → $3 | Downgrade | Buy → Hold | Get Alert |
FAQ
What is the target price for Athira Pharma (ATHA) stock?
The latest price target for Athira Pharma (NASDAQ:ATHA) was reported by Mizuho on September 19, 2024. The analyst firm set a price target for $0.50 expecting ATHA to rise to within 12 months (a possible 56.25% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Athira Pharma (ATHA)?
The latest analyst rating for Athira Pharma (NASDAQ:ATHA) was provided by Mizuho, and Athira Pharma downgraded their neutral rating.
When was the last upgrade for Athira Pharma (ATHA)?
There is no last upgrade for Athira Pharma
When was the last downgrade for Athira Pharma (ATHA)?
The last downgrade for Athira Pharma Inc happened on September 19, 2024 when Mizuho changed their price target from $5 to $0.5 for Athira Pharma Inc.
When is the next analyst rating going to be posted or updated for Athira Pharma (ATHA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Athira Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Athira Pharma was filed on September 19, 2024 so you should expect the next rating to be made available sometime around September 19, 2025.
Is the Analyst Rating Athira Pharma (ATHA) correct?
While ratings are subjective and will change, the latest Athira Pharma (ATHA) rating was a downgraded with a price target of $5.00 to $0.50. The current price Athira Pharma (ATHA) is trading at is $0.32, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
